BNP Paribas Asset Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.6M | Buy |
|
|||||
|
2025
Q1 | $20.9M | Sell |
|
|||||
|
2024
Q4 | $27.3M | Sell |
|
|||||
|
2024
Q3 | $77.4M | Sell |
|
|||||
|
2024
Q2 | $100M | Sell |
|
|||||
|
2024
Q1 | $123M | Buy |
|
|||||
|
2023
Q4 | $116M | Sell |
|
|||||
|
2023
Q3 | $170M | Buy |
|
|||||
|
2023
Q2 | $157M | Buy |
|
|||||
|
2023
Q1 | $114M | Buy |
|
|||||
|
2022
Q4 | $107M | Buy |
|
|||||
|
2022
Q3 | $92.5M | Sell |
|
|||||
|
2022
Q2 | $71M | Buy |
|
|||||
|
2022
Q1 | $73.1M | Buy |
|
|||||
|
2021
Q4 | $58.5M | Sell |
|
|||||
|
2021
Q3 | $85.7M | Buy |
|
|||||
|
2021
Q2 | $90.5M | Sell |
|
|||||
|
2021
Q1 | $80.9M | Buy |
|
|||||
|
2020
Q4 | $63.4M | Buy |
|
|||||
|
2020
Q3 | $71M | Buy |
|
|||||
|
2020
Q2 | $42M | Sell |
|
|||||
|
2020
Q1 | $53.4M | Buy |
|
|||||
|
2019
Q4 | $48.9M | Buy |
|
|||||
|
2019
Q3 | $33M | Buy |
|
|||||
|
2019
Q2 | $24.2M | Sell |
|
|||||
|
2019
Q1 | $34.4M | Buy |
|
|||||
|
2018
Q4 | $35.4M | Buy |
|
|||||
|
2018
Q3 | $38.4M | Buy |
|
|||||
|
2018
Q2 | $27M | Sell |
|
|||||
|
2018
Q1 | $30.4M | Buy |
|
|||||
|
2017
Q4 | $28.8M | Buy |
|
|||||
|
2017
Q3 | $23.7M | Sell |
|
|||||
|
2017
Q2 | $20.8M | Sell |
|
|||||
|
2017
Q1 | $21.2M | Sell |
|
|||||
|
2016
Q4 | $24.4M | Buy |
|
|||||
|
2016
Q3 | $22.2M | Buy |
|
|||||
|
2016
Q2 | $14.1M | Sell |
|
|||||
|
2016
Q1 | $42.7M | Sell |
|
|||||
|
2015
Q4 | $66.2M | Sell |
|
|||||
|
2015
Q3 | $66.8M | Buy |
|
|||||
|
2015
Q2 | $90.4M | Sell |
|
|||||
|
2015
Q1 | $124M | Buy |
|
|||||
|
2014
Q4 | $62.1M | Sell |
|
|||||
|
2014
Q3 | $64.9M | Sell |
|
|||||
|
2014
Q2 | $69.2M | Sell |
|
|||||
|
2014
Q1 | $99.5M | Buy |
|
|||||
|
2013
Q4 | $86M | Sell |
|
|||||
|
2013
Q3 | $91M | Sell |
|
|||||
|
2013
Q2 | $96.5M | Buy |
|